Fundsmith Investment Services LTD. Has $459.51 Million Holdings in Stryker Corporation $SYK

Fundsmith Investment Services LTD. decreased its stake in Stryker Corporation (NYSE:SYK) by 15.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,307,407 shares of the medical technology company’s stock after selling 246,373 shares during the period. Stryker accounts for approximately 8.4% of Fundsmith Investment Services LTD.’s holdings, making the stock its largest position. Fundsmith Investment Services LTD.’s holdings in Stryker were worth $459,514,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of SYK. Norges Bank bought a new position in shares of Stryker in the 4th quarter valued at about $1,822,272,000. Corient Private Wealth LLC grew its holdings in Stryker by 104.4% during the second quarter. Corient Private Wealth LLC now owns 2,245,841 shares of the medical technology company’s stock worth $887,525,000 after purchasing an additional 1,146,998 shares during the period. Alliancebernstein L.P. grew its holdings in Stryker by 13.3% during the third quarter. Alliancebernstein L.P. now owns 6,338,050 shares of the medical technology company’s stock worth $2,342,987,000 after purchasing an additional 741,542 shares during the period. Strive Asset Management LLC bought a new position in Stryker during the third quarter worth about $227,389,000. Finally, Credit Agricole S A bought a new position in Stryker during the third quarter worth about $194,045,000. Institutional investors own 77.09% of the company’s stock.

Insider Transactions at Stryker

In other news, VP M Kathryn Fink sold 3,500 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $283.45, for a total transaction of $992,075.00. Following the completion of the sale, the vice president owned 177 shares in the company, valued at $50,170.65. The trade was a 95.19% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, VP Robert S. Fletcher sold 4,544 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $306.87, for a total value of $1,394,417.28. Following the sale, the vice president owned 10,582 shares of the company’s stock, valued at approximately $3,247,298.34. This represents a 30.04% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 323,264 shares of company stock worth $100,659,489 over the last quarter. Company insiders own 4.60% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently issued reports on SYK shares. Jefferies Financial Group reaffirmed a “buy” rating and issued a $465.00 price objective on shares of Stryker in a research report on Wednesday, March 4th. The Goldman Sachs Group reiterated a “neutral” rating and set a $361.00 target price on shares of Stryker in a research note on Friday, May 1st. UBS Group reduced their target price on Stryker from $400.00 to $380.00 and set a “neutral” rating for the company in a research note on Tuesday, March 17th. William Blair reiterated an “outperform” rating on shares of Stryker in a research note on Thursday, March 5th. Finally, Sanford C. Bernstein set a $410.00 target price on Stryker in a research note on Friday, May 1st. Sixteen analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $395.33.

Stryker Trading Up 0.9%

Shares of NYSE:SYK opened at $310.71 on Wednesday. Stryker Corporation has a 12-month low of $281.00 and a 12-month high of $404.87. The stock has a market cap of $119.11 billion, a PE ratio of 35.96, a P/E/G ratio of 1.97 and a beta of 0.78. The business has a 50 day moving average of $315.51 and a 200-day moving average of $342.88. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). Stryker had a return on equity of 23.42% and a net margin of 13.20%.The firm had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $6.34 billion. During the same quarter in the prior year, the firm earned $2.84 EPS. The company’s revenue was up 2.6% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, equities research analysts forecast that Stryker Corporation will post 14.98 earnings per share for the current year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Tuesday, June 30th. Stryker’s payout ratio is currently 40.74%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.